Advertisement
U.S. Markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.1700+0.0800 (+7.34%)
At close: 04:00PM EDT
1.1900 +0.02 (+1.71%)
After hours: 05:38PM EDT
Advertisement
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
29,286
47,468
30,383
24,537
32,126
-
Operating Income
-29,286
-47,468
-30,383
-24,537
-32,126
-
Net Non Operating Interest Income Expense
-3,213
-1,428
-2,361
-5,553
-17,945
-
Other Income Expense
-10,656
11,138
-11,389
-60,769
-1,192
-
Pretax Income
-43,155
-37,758
-44,133
-90,859
-51,263
-
Tax Provision
371
613
301
705
743
-
Net Income Common Stockholders
-43,526
-38,371
-44,434
-91,564
-52,006
-
Diluted NI Available to Com Stockholders
-43,526
-38,371
-44,434
-91,564
-52,006
-
Basic EPS
-2.43
-2.73
-3.35
-7.74
-30.01
-
Diluted EPS
-2.43
-2.73
-3.35
-7.74
-30.01
-
Basic Average Shares
12,740
14,060
13,273
11,813
1,736
-
Diluted Average Shares
12,740
14,060
13,273
11,813
1,736
-
Total Operating Income as Reported
-29,286
-47,468
-30,383
-24,537
-32,126
-
Total Expenses
29,286
47,468
30,383
24,537
32,126
-
Net Income from Continuing & Discontinued Operation
-43,526
-38,371
-44,434
-91,564
-52,006
-
Normalized Income
-47,162
-47,105
-48,746
-47,060
-50,980
-
Interest Expense
3,213
1,428
2,361
5,553
15,097
-
Net Interest Income
-3,213
-1,428
-2,361
-5,553
-17,945
-
EBIT
-39,942
-36,330
-41,772
-85,306
-36,166
-
EBITDA
-36,808
-34,580
-39,972
-83,202
-36,005
-
Reconciled Depreciation
3,134
1,750
1,800
2,104
161
-
Net Income from Continuing Operation Net Minority Interest
-43,526
-38,371
-44,434
-91,564
-52,006
-
Total Unusual Items Excluding Goodwill
6,060
11,056
5,458
-60,964
-1,405
-
Total Unusual Items
6,060
11,056
5,458
-60,964
-1,405
-
Normalized EBITDA
-42,868
-45,636
-45,430
-22,238
-34,600
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
2,424
2,322
1,146
-16,460
-379.35
-